FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.33
Tradestie Score
32
Market Cap
$144.16M
Revenue Growth
0.1%
Analyst Upside
+146.5%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REPL
Replimune Group, Inc.
|
$14.77
|
$328.62M | - | 30 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$17.19
|
$308.74M | - | 48 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$13.13
|
$304.12M | - | 35 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 47 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.63
|
$293.03M | - | 30 | Compare |
|
OMER
Omeros Corporation
|
$19.27
|
$281.75M | 11.2 | 35 | Compare |
|
DBVT
DBV Technologies S.A.
|
$14.55
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.09
|
$275.13M | - | 46 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$23.36
|
$269.08M | 0.1 | 48 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.85
|
$262.67M | - | 48 | Compare |
More FATE Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry